Immune Pharmaceuticals Inc
OTC:IMNPQ
Income Statement
Earnings Waterfall
Immune Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-14.7m
USD
|
Operating Income
|
-14.7m
USD
|
Other Expenses
|
-19.7m
USD
|
Net Income
|
-34.4m
USD
|
Income Statement
Immune Pharmaceuticals Inc
Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
+26%
|
0
+15%
|
0
+10%
|
0
-2%
|
1
+19%
|
1
+32%
|
1
+21%
|
1
+25%
|
1
+4%
|
1
-3%
|
1
+2%
|
1
-8%
|
1
N/A
|
0
-48%
|
0
-57%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+66%
|
0
-42%
|
0
N/A
|
(0)
N/A
|
(0)
-1 200%
|
0
N/A
|
0
+525%
|
0
+36%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(22)
|
(22)
|
(20)
|
(20)
|
(19)
|
(29)
|
(27)
|
(26)
|
(15)
|
(14)
|
(14)
|
(15)
|
(14)
|
(14)
|
(11)
|
(10)
|
(10)
|
(9)
|
(10)
|
(9)
|
(9)
|
(4)
|
(5)
|
(16)
|
(16)
|
(17)
|
(17)
|
(14)
|
(16)
|
(17)
|
(17)
|
(17)
|
(15)
|
(26)
|
(25)
|
(12)
|
(12)
|
(18)
|
(14)
|
(15)
|
|
Selling, General & Administrative |
(10)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(11)
|
(11)
|
(10)
|
(10)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
|
Research & Development |
(13)
|
(11)
|
(12)
|
(12)
|
(12)
|
(11)
|
(10)
|
(9)
|
(8)
|
(8)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(6)
|
(6)
|
(7)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
(12)
|
0
|
0
|
(4)
|
0
|
0
|
|
Operating Income |
(22)
N/A
|
(22)
0%
|
(20)
+9%
|
(20)
+2%
|
(19)
+4%
|
(28)
-50%
|
(27)
+5%
|
(26)
+4%
|
(15)
+40%
|
(14)
+7%
|
(14)
N/A
|
(15)
-3%
|
(14)
+5%
|
(14)
+3%
|
(11)
+19%
|
(10)
+12%
|
(10)
-1%
|
(9)
+7%
|
(10)
-5%
|
(9)
+11%
|
(9)
-6%
|
(4)
+60%
|
(5)
-30%
|
(16)
-231%
|
(16)
-5%
|
(17)
-3%
|
(17)
+1%
|
(14)
+18%
|
(16)
-15%
|
(17)
-9%
|
(17)
0%
|
(17)
-1%
|
(15)
+15%
|
(26)
-73%
|
(25)
+0%
|
(12)
+54%
|
(12)
-3%
|
(18)
-46%
|
(14)
+22%
|
(15)
-6%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(20)
|
(21)
|
(20)
|
(39)
|
(12)
|
(11)
|
(10)
|
(1)
|
0
|
1
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
1
|
(1)
|
(4)
|
(2)
|
(6)
|
(4)
|
(1)
|
(2)
|
(2)
|
(10)
|
(10)
|
(11)
|
(12)
|
(5)
|
(3)
|
(2)
|
(1)
|
0
|
|
Non-Reccuring Items |
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
(15)
|
(4)
|
0
|
(5)
|
(3)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
(1)
|
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(25)
N/A
|
(42)
-65%
|
(41)
+2%
|
(40)
+3%
|
(58)
-46%
|
(40)
+31%
|
(38)
+5%
|
(36)
+4%
|
(16)
+57%
|
(13)
+13%
|
(13)
+4%
|
(15)
-17%
|
(16)
-3%
|
(17)
-7%
|
(16)
+6%
|
(13)
+15%
|
(13)
+6%
|
(11)
+12%
|
(10)
+12%
|
(5)
+49%
|
(6)
-16%
|
(9)
-48%
|
(6)
+26%
|
(20)
-213%
|
(24)
-18%
|
(22)
+5%
|
(25)
-14%
|
(18)
+31%
|
(17)
+3%
|
(19)
-9%
|
(19)
-4%
|
(28)
-42%
|
(38)
-36%
|
(36)
+4%
|
(38)
-4%
|
(31)
+17%
|
(20)
+37%
|
(20)
-3%
|
(20)
+1%
|
(18)
+9%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
5
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(25)
|
(42)
|
(41)
|
(40)
|
(58)
|
(40)
|
(38)
|
(36)
|
(16)
|
(14)
|
(13)
|
(15)
|
(16)
|
(17)
|
(16)
|
(13)
|
(13)
|
(11)
|
(10)
|
(5)
|
(6)
|
(9)
|
(6)
|
(20)
|
(24)
|
(22)
|
(25)
|
(18)
|
(17)
|
(19)
|
(20)
|
(28)
|
(33)
|
(31)
|
(33)
|
(26)
|
(20)
|
(20)
|
(20)
|
(18)
|
|
Net Income (Common) |
(25)
N/A
|
(42)
-65%
|
(41)
+2%
|
(40)
+3%
|
(58)
-46%
|
(40)
+31%
|
(38)
+5%
|
(36)
+4%
|
(16)
+57%
|
(14)
+13%
|
(13)
+4%
|
(15)
-17%
|
(16)
-3%
|
(18)
-14%
|
(16)
+13%
|
(13)
+15%
|
(13)
+6%
|
(10)
+22%
|
(10)
-3%
|
(6)
+42%
|
(7)
-13%
|
(9)
-42%
|
(7)
+21%
|
(21)
-178%
|
(24)
-17%
|
(25)
-2%
|
(26)
-3%
|
(23)
+10%
|
(24)
-4%
|
(25)
-3%
|
(29)
-18%
|
(37)
-27%
|
(41)
-10%
|
(38)
+6%
|
(38)
+2%
|
(26)
+30%
|
(25)
+6%
|
(25)
-3%
|
(31)
-21%
|
(34)
-12%
|
|
EPS (Diluted) |
-846.33
N/A
|
-1 045
-23%
|
-822.2
+21%
|
-795.2
+3%
|
-966
-21%
|
-666.33
+31%
|
-629.83
+5%
|
-602.5
+4%
|
-222
+63%
|
-168.75
+24%
|
-143.89
+15%
|
-168.67
-17%
|
-174
-3%
|
-178.9
-3%
|
-48.84
+73%
|
-95.29
-95%
|
-83.8
+12%
|
-54.78
+35%
|
-53.68
+2%
|
-11.4
+79%
|
-9.99
+12%
|
-13.94
-40%
|
-10.38
+26%
|
-24.74
-138%
|
-13.61
+45%
|
-20.25
-49%
|
-17.99
+11%
|
-16.87
+6%
|
-15.87
+6%
|
-14.35
+10%
|
-13.68
+5%
|
-6.72
+51%
|
-5.37
+20%
|
-4.36
+19%
|
-3.81
+13%
|
-2.33
+39%
|
-1.46
+37%
|
-0.85
+42%
|
-2.49
-193%
|
-0.87
+65%
|